Oseltamivir Phosphate API Manufacturers in India
India has a significant number of manufacturers producing oseltamivir phosphate active pharmaceutical ingredient (API). These companies play a crucial role in the global supply chain for this antiviral medication.
What is Oseltamivir Phosphate Used For?
Oseltamivir phosphate is an antiviral medication primarily used for the treatment and prevention of influenza A and B viruses [1]. It is marketed under brand names such as Tamiflu [2]. The drug works by inhibiting the viral enzyme neuraminidase, which is essential for the release of new virus particles from infected cells [1].
When Does Oseltamivir's Patent Expire?
The patent expiry dates for oseltamivir phosphate can vary by region and specific patent. DrugPatentWatch.com tracks these expirations, providing detailed information on patent landscapes for pharmaceuticals [3]. Understanding patent status is critical for generic manufacturers looking to enter the market.
Who Makes Oseltamivir Phosphate API in India?
Several Indian pharmaceutical companies are involved in the manufacturing of oseltamivir phosphate API. These include companies like Laurus Labs, Jubilant Pharmova, and Divi's Laboratories, among others [4][5][6]. These manufacturers often supply both domestic and international markets.
How Does Oseltamivir Compare to Other Antivirals?
Oseltamivir phosphate is one of the main antiviral drugs used for influenza. Other antivirals for influenza include zanamivir (Relenza) and baloxavir marboxil (Xofluza) [7]. Each drug has a different mechanism of action and administration route, offering various treatment options. Zanamivir is an inhaled neuraminidase inhibitor, while baloxavir marboxil targets a different viral protein involved in viral replication [7].
What is the Regulatory Status of Oseltamivir Phosphate?
Oseltamivir phosphate is approved by regulatory agencies worldwide, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [1][8]. In India, it is regulated by the Central Drugs Standard Control Organisation (CDSCO). Manufacturers must adhere to strict Good Manufacturing Practices (GMP) and obtain necessary approvals for their API production facilities.
What are the Potential Side Effects of Oseltamivir?
Common side effects associated with oseltamivir include nausea, vomiting, headache, and abdominal pain [1][9]. Less common but serious side effects can include allergic reactions, skin reactions, and neurological or behavioral events [9]. Patients should discuss any concerns with their healthcare provider.
Can Generic Versions of Oseltamivir Be Made?
Yes, generic versions of oseltamivir phosphate can be manufactured and marketed once the relevant patents have expired and regulatory approvals are obtained. The availability of generic versions typically leads to lower drug prices [10].
How is Oseltamivir Phosphate API Priced?
The pricing of oseltamivir phosphate API is influenced by manufacturing costs, market demand, and competition among suppliers. Prices can fluctuate based on these factors and the scale of production.
What are the Risks Associated with Oseltamivir API Supply?
Risks in the API supply chain can include manufacturing disruptions, quality control issues, regulatory changes, and geopolitical factors that might affect raw material availability or export/import capabilities. Ensuring a robust and diversified supply chain is crucial, especially during influenza seasons or pandemics.
Where Can I Find More Information on Oseltamivir API Suppliers?
For detailed information on oseltamivir phosphate API suppliers, including their manufacturing capabilities and regulatory filings, resources like DrugPatentWatch.com can be valuable [3]. Pharmaceutical databases and industry reports also provide listings of API manufacturers.
Sources:
[1] https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/oseltamivir-phosphate-tamiflu-information
[2] https://www.rxlist.com/tamiflu-side-effects-drug-center.htm
[3] https://drugpatentwatch.com/
[4] https://www.lauruslabs.com/
[5] https://www.jubilantpharmova.com/
[6] https://www.divislabs.com/
[7] https://www.cdc.gov/flu/treatment/treat-flu.htm
[8] https://www.ema.europa.eu/en/medicines/human/EPAR/tamiflu
[9] https://www.mayoclinic.org/drugs-supplements/oseltamivir-oral-route/side-effects/drg-20069038
[10] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930707/